PUXANO operates as a platform-based biotech company, grounded in experimental structural biology and empowered by diffusion-based generative AI.
We provide R&D services for pharmaceutical, biotechnology and agritech companies advancing protein therapeutics, vaccine development and crop protection.
Thanks to our platform PROTAGON, propelled by proprietary molecular, structural and computational technologies, we can unlock targets previously deemed inaccessible or facilitate the streamlined design, production and validation of engineered proteins with exceptional efficiency.
Current platforms are:
- procondor, a software tool for automated protein construct design.
- UltraP, a set of biotechnology workflows and tools for high-throughput protein production and biophysical characterization
- PXN Grids, a portfolio of proprietary cryo-EM grids and sample preparation protocols resolving the major bottlenecks in cryoEM sample preparation.
For more information, please visit our website 𝘄𝘄𝘄.𝗽𝘂𝘅𝗮𝗻𝗼.𝗰𝗼𝗺 or contact 𝗶𝗻𝗳𝗼@𝗽𝘂𝘅𝗮𝗻𝗼.𝗰𝗼𝗺.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Ottergemsesteenweg Zuid 713, Ghent,flemish Region 9000,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.puxano.com
- Keywords
- Protein Biochemistry, Nanotechnology, Structural Biology, Cryo-electron microscopy, Biotechnology, micro/nanofabrication.
- HQ
- Ghent, Flemish Region
Puxano Questions
Puxano's website is https://www.puxano.com
Puxano's LinkedIn profile is https://be.linkedin.com/company/puxano
Puxano has
7 employees.
View email and phone details for 7
employees at Puxano.
Puxano's industry is
Biotechnology Research
Puxano's top competitors are
Landman.bio,
Mycartis,
It4innovations National Supercomputing Center,
Ziphius,
Helix Biostructures,
Vib,
Faqir Institute,
Medex.health,
Flyblast,
Xtal Biostructures, Inc..
Puxano's categories are Biotechnology Research
Puxano's founding year is 2021
